Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q1

4521.TEDINET S100RKL3
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥18.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥18.2bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥3.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥4.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥3.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥3.5bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥4.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥167.2bnat 2023-06-30Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥165.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥29.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥137.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥137.9bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥56.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥66.992023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.912022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.0bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-06-30¥321m
—segment totalrevenue2023-04-01 → 2023-06-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.3bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-06-30¥295m
—segment totalrevenue2022-04-01 → 2022-06-30¥18.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥18.2bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 374
ItemContextValueUnit
Bonuses and provision for bonuses sgaPrior1YTDDuration307000000JPY
Bonuses and provision for bonuses sgaCurrentYTDDuration297000000JPY
Retirement benefit expenses sgaPrior1YTDDuration85000000JPY
Retirement benefit expenses sgaCurrentYTDDuration68000000JPY
Research and development expenses sgaPrior1YTDDuration2030000000JPY
Research and development expenses sgaCurrentYTDDuration2600000000JPY
Other sgaPrior1YTDDuration2153000000JPY
Other sgaCurrentYTDDuration2379000000JPY
Selling general and administrative expensesPrior1YTDDuration5983000000JPY
Selling general and administrative expensesCurrentYTDDuration6762000000JPY
Operating incomePrior1YTDDuration4056000000JPY
Operating incomeCurrentYTDDuration3293000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration2000000JPY
Dividends income noiPrior1YTDDuration229000000JPY
Dividends income noiCurrentYTDDuration247000000JPY
Other noiPrior1YTDDuration50000000JPY
Other noiCurrentYTDDuration7000000JPY
Non operating incomePrior1YTDDuration281000000JPY
Non operating incomeCurrentYTDDuration256000000JPY
Interest expenses noePrior1YTDDuration4000000JPY
Interest expenses noeCurrentYTDDuration4000000JPY
Foreign exchange losses noePrior1YTDDuration－JPY
Foreign exchange losses noeCurrentYTDDuration52000000JPY
Other noePrior1YTDDuration1000000JPY
Other noeCurrentYTDDuration5000000JPY
Non operating expensesPrior1YTDDuration5000000JPY
Non operating expensesCurrentYTDDuration61000000JPY
Ordinary incomePrior1YTDDuration4332000000JPY
Ordinary incomeCurrentYTDDuration3488000000JPY
Other eiPrior1YTDDuration0JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration19000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration37000000JPY
Impairment loss elPrior1YTDDuration304000000JPY
Impairment loss elCurrentYTDDuration－JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration0JPY
Extraordinary lossPrior1YTDDuration324000000JPY
Extraordinary lossCurrentYTDDuration38000000JPY
Income before income taxesPrior1YTDDuration4008000000JPY
Income before income taxesCurrentYTDDuration3451000000JPY
Income taxesPrior1YTDDuration1100000000JPY
Income taxesCurrentYTDDuration940000000JPY
Profit lossPrior1YTDDuration2907000000JPY
Profit lossCurrentYTDDuration2510000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass